Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Rouanne

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Nature Reviews. Cancer|August 11, 2021
Targeting the DNA damage response in immuno-oncology: developments and opportunitiesRoman M Chabanon, Mathieu Rouanne, Christopher J Lord, et al.
Urologia Internationalis|November 17, 2011
Management of renal cell carcinoma in sigmoid kidneyMathieu Rouanne, Guillaume Legrand, Raphaëlle Renard-Penna, et al.
Clinical Genitourinary Cancer|December 18, 2014
Trends in renal function after radical cystectomy and ileal conduit diversion: new insights regarding estimated glomerular filtration rate variationsMathieu Rouanne, Aurore Perreaud, Nicolas Letang, et al.
Urologic Oncology|August 25, 2021
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UCMyriam Kossaï, Camélia Radulescu, Julien Adam, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Rationale for LDH-targeted cancer immunotherapyTina B S Miholjcic, Heloise Halse, Mélodie Bonvalet, et al.
European Urology Oncology|November 12, 2020
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the BladderMathieu Rouanne, Dean F Bajorin, Raquibul Hannan, et al.
Plos One|February 28, 2019
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk scoreMarie Simon, Pierre-Olivier Bosset, Mathieu Rouanne, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancerMathieu Rouanne, Reem Betari, Camélia Radulescu, et al.
Frontiers in Oncology|October 29, 2020
The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder CarcinomaAntoine Girard, Helena Vila Reyes, Hiram Shaish, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2012
Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a Phase I clinical trial unit of predominantly targeted anticancer drugsMathieu Rouanne, Christophe Massard, Antoine Hollebecque, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Nature Reviews. Cancer|August 11, 2021
Targeting the DNA damage response in immuno-oncology: developments and opportunitiesRoman M Chabanon, Mathieu Rouanne, Christopher J Lord, et al.
Urologia Internationalis|November 17, 2011
Management of renal cell carcinoma in sigmoid kidneyMathieu Rouanne, Guillaume Legrand, Raphaëlle Renard-Penna, et al.
Clinical Genitourinary Cancer|December 18, 2014
Trends in renal function after radical cystectomy and ileal conduit diversion: new insights regarding estimated glomerular filtration rate variationsMathieu Rouanne, Aurore Perreaud, Nicolas Letang, et al.
Urologic Oncology|August 25, 2021
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UCMyriam Kossaï, Camélia Radulescu, Julien Adam, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Rationale for LDH-targeted cancer immunotherapyTina B S Miholjcic, Heloise Halse, Mélodie Bonvalet, et al.
European Urology Oncology|November 12, 2020
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the BladderMathieu Rouanne, Dean F Bajorin, Raquibul Hannan, et al.
Plos One|February 28, 2019
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk scoreMarie Simon, Pierre-Olivier Bosset, Mathieu Rouanne, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancerMathieu Rouanne, Reem Betari, Camélia Radulescu, et al.
Frontiers in Oncology|October 29, 2020
The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder CarcinomaAntoine Girard, Helena Vila Reyes, Hiram Shaish, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2012
Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a Phase I clinical trial unit of predominantly targeted anticancer drugsMathieu Rouanne, Christophe Massard, Antoine Hollebecque, et al.
Pageof 6